Variability in the prescription of drugs with uncertain effectiveness. The case of SYSADOA in the Basque Country

Background: The majority of clinical practice guidelines do not recommend the use of SYSADOA (Symptomatic Slow Action Drugs for Osteoarthritis) for the treatment of osteoarthritis because of the lack of evidence or uncertainty around their efficacy. Nevertheless, the Spanish Public Health Service co...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibargoyen-Roteta, Nora, Mateos del Pino, Maider, Gutiérrez-Ibarluzea, Iñaki, Benguria-Arrate, Gaizka, Rada-Fernández de Jauregui, Diego, Domingo-Rico, Cristina, Regidor Fuentes, Iratxe, González Santisteban, Roberto, Armendáriz Cuñado, María, Jaio Atela, Nekane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460939/
https://www.ncbi.nlm.nih.gov/pubmed/31015866
http://dx.doi.org/10.3205/hta000130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460939/
https://www.ncbi.nlm.nih.gov/pubmed/31015866
http://dx.doi.org/10.3205/hta000130

Ejemplares similares